SEC Form 4/A · accession 0001209191-15-025707
ANTARES PHARMA, INC. · ATRS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Robert F Apple
Officer — Executive Vice President & COO
Period of report
May 21, 2014
Accepted (ET)
Mar 12, 2015 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016169
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 21, 2014 | F | 3,526 | $2.97 | D | 340,392 | D | |
| Common StockF2,F3 | Feb 10, 2015 | A | 12,519 | $0.00 | A | 360,234 | D | |
| Common StockF3 | Feb 10, 2015 | F | 4,779 | $2.36 | D | 355,455 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares withheld for tax purposes were not timely reported.
- F2On July 6, 2012, Mr. Apple received a performance stock unit award under the 2008 Equity Compensation Plan. The target number of shares under the award is 25,039 shares, and the award is contingent upon the Company's achieving certain performance goals over the three-year period beginning January 1, 2012 and ending December 31, 2014. The 12,519 shares reported here represent the number of shares vested on February 10, 2015 upon the Company's achievement of a performance goal. 12,520 shares of the award remain subject to performance goals and may be earned by Mr. Apple pursuant to the terms of the award. Until earned, they have been removed from the amount of securities beneficially owned.
- F3Includes 32,362 shares of restricted common stock granted to Mr. Apple on 05/29/2014 and reported on a Form 4 dated 06/02/2014. The original Form 4 filed on 02/12/2015 did not include these 32,362 shares of restricted common stock.